FILTER
Refine your search with the following facets to narrow down your results.
- amyotrophic lateral sclerosis 6
- cancer 6
- phase III studies 6
- diabetes 5
- diseases 5
- prostate cancer 5
- AIDS 4
- Parkinson's disease 4
- Sanofi-aventis 4
- antibodies 4
- biotechnology 4
- breast cancer 4
- impetigo 4
- myocardial infarction 4
- phase I studies 4
- vaccines 4
- HIV 3
- Life Sciences 3
- Orphan Drug Designation 3
- Ozenoxacin 3
- T cells 3
- acquisitions 3
- active pharmaceutical ingredients 3
- chemotherapy 3
- infectious diseases 3
- insulin 3
- metabolic diseases 3
- mitochondria 3
- progressive multifocal leukoencephalopathy 3
- research collaborations 3
- toxicity 3
- vitamin D 3
- Alzheimer's disease 2
- Belgium 2
- Crohn's disease 2
- Huntington's disease 2
- Italy 2
- Series A financing 2
- Spain 2
- anti-infectives 2
- atrophy 2
- bioinformatics 2
- biomarkers 2
- cardiovascular diseases 2
- cell lines 2
- cholesterol 2
- chronic renal disease 2
- coronaviruses 2
- diagnostic tests 2
- dosing 2
- dry eye syndrome 2
- ghrelin 2
- immunogenicity 2
- immunology 2
- immunotherapies 2
- inecalcitol 2
- kinase inhibitors 2
- laboratories 2
- medical devices 2
- membrane proteins 2
- neurological diseases 2
- oncology 2
- ophthalmology 2
- peptides 2
- prostate-specific antigen 2
- proteomics 2
- rare diseases 2
- scale-up 2
- stem cells 2
- validation 2
- viruses 2
- Amgen 1
- Arteria 1
- BASF 1
- CNS disorders 1
- CNS drugs 1
- Coronavirus testing 1
- Covid-19 1
- Daiichi Sankyo 1
- Dairy 1
- Duchenne muscular dystrophy 1
- Eli Lilly 1
- G protein-coupled receptors 1
- GLP 1
- GSK 1
- Gemcitabine 1
- Germany 1
- Glycosylation 1
- Gougerot-Sjogren syndrome 1
- HPV 1
- Hydrolysis 1
- Japan 1
- Life Science 1
- Lilly 1
- Lonza 1
- Groupe Novasep 9
- Rhenovia Pharma SAS 6
- Ferrer Internacional 5
- Oncodesign SA 5
- Adocia SAS 4
- Alizé Pharma 4
- Domain Therapeutics S.A. 4
- Genticel S.A. 4
- Provence Technologies SAS 4
- Provepharm SAS 4
- Ariana Pharma 3
- CIT 3
- European Medicines Agency (EMA) 3
- TxCell SA 3
- Vaxon Biotech 3
- Acobiom 2
- Calixar 2
- Immutep S.A 2
- Integromics S.L. 2
- Ipsen 2
- LAB Research Inc. 2
- Neuroptis Biotech 2
- Prexton Therapeutics 2
- Promethera Biosciences S.A./N.V. 2
- sanofi-aventis Groupe 2
- 3d Communication 1
- Arteria SA 1
- Assistance Publique-Hôpitaux de Paris (AP-HP) 1
- Bertin Pharma Directions Parc d’activités du Pas du Lac 1
- BioBank for Life 1
- Biom'Up 1
- COVALAB S.A.R.L 1
- Cancer Immunotherapy Trials Network (CITN) 1
- Centre Léon Bérard 1
- CiToxLAB 1
- DNA Therapeutics SA 1
- Daiichi Sankyo Company, Limited 1
- EYETECHCARE, Limited 1
- Eli Lilly and Company 1
- Enterome 1
- European Patent Office (EPO) / Europäisches Patentamt (EPA) 1
- Exciva GmbH 1
- EyeBrain SA 1
- French National Institute of Health and Medical Research 1
- GlaxoSmithKline plc (GSK) 1
- Guerbet 1
- Harmonic Pharma 1
- Helios BioSciences 1
- ImmunID Technologies 1
- InGen BioSciences 1
- Inserm Transfert SA 1
- Institut Curie 1
- Inventiva 1
- Kallistem 1
- Katholieke Universiteit Leuven 1
- Lonza Group Ltd 1
- Max-Planck-Institut für Multidisziplinäre Naturwissenschaften 1
- Metabolium 1
- Michell Instruments GmbH 1
- MorphoSys AG 1
- Mutabilis SA 1
- NUTRITIS 1
- NexGenix Pharmaceuticals Holdings, Inc. 1
- NovAliX SAS 1
- OSEO 1
- Ono Pharmaceutical Co., Ltd. 1
- Oroxcell SAS 1
- Oxford Medical Diagnostics Ltd 1
- Pharma Omnium International SAS 1
- Pharma Plexus Holland BV 1
- PharmaDiagnostics NV 1
- Prestwick Chemical, Inc. 1
- PupPharma S.A.S. 1
- Quinten 1
- Regulaxis 1
- Ricerca Biosciences 1
- SOLVO Biotechnology 1
- Sebia 1
- Servier 1
- Spartha Medical 1
- Synthelis 1
- U. S. Food and Drug Administration (FDA) 1
- U.S. Patent & Trademark Office (USPTO) 1
- Université Pierre et Marie Curie 1
- Vésale Bioscience 1
- Xencor, Inc. 1
- instrAction GmbH 1
FILTERS
Refine your search with the following facets to narrow down your results.
- amyotrophic lateral sclerosis 6
- cancer 6
- phase III studies 6
- diabetes 5
- diseases 5
- prostate cancer 5
- AIDS 4
- Parkinson's disease 4
- Sanofi-aventis 4
- antibodies 4
- biotechnology 4
- breast cancer 4
- impetigo 4
- myocardial infarction 4
- phase I studies 4
- vaccines 4
- HIV 3
- Life Sciences 3
- Orphan Drug Designation 3
- Ozenoxacin 3
- T cells 3
- acquisitions 3
- active pharmaceutical ingredients 3
- chemotherapy 3
- infectious diseases 3
- insulin 3
- metabolic diseases 3
- mitochondria 3
- progressive multifocal leukoencephalopathy 3
- research collaborations 3
- toxicity 3
- vitamin D 3
- Alzheimer's disease 2
- Belgium 2
- Crohn's disease 2
- Huntington's disease 2
- Italy 2
- Series A financing 2
- Spain 2
- anti-infectives 2
- atrophy 2
- bioinformatics 2
- biomarkers 2
- cardiovascular diseases 2
- cell lines 2
- cholesterol 2
- chronic renal disease 2
- coronaviruses 2
- diagnostic tests 2
- dosing 2
- dry eye syndrome 2
- ghrelin 2
- immunogenicity 2
- immunology 2
- immunotherapies 2
- inecalcitol 2
- kinase inhibitors 2
- laboratories 2
- medical devices 2
- membrane proteins 2
- neurological diseases 2
- oncology 2
- ophthalmology 2
- peptides 2
- prostate-specific antigen 2
- proteomics 2
- rare diseases 2
- scale-up 2
- stem cells 2
- validation 2
- viruses 2
- Amgen 1
- Arteria 1
- BASF 1
- CNS disorders 1
- CNS drugs 1
- Coronavirus testing 1
- Covid-19 1
- Daiichi Sankyo 1
- Dairy 1
- Duchenne muscular dystrophy 1
- Eli Lilly 1
- G protein-coupled receptors 1
- GLP 1
- GSK 1
- Gemcitabine 1
- Germany 1
- Glycosylation 1
- Gougerot-Sjogren syndrome 1
- HPV 1
- Hydrolysis 1
- Japan 1
- Life Science 1
- Lilly 1
- Lonza 1
- Groupe Novasep 9
- Rhenovia Pharma SAS 6
- Ferrer Internacional 5
- Oncodesign SA 5
- Adocia SAS 4
- Alizé Pharma 4
- Domain Therapeutics S.A. 4
- Genticel S.A. 4
- Provence Technologies SAS 4
- Provepharm SAS 4
- Ariana Pharma 3
- CIT 3
- European Medicines Agency (EMA) 3
- TxCell SA 3
- Vaxon Biotech 3
- Acobiom 2
- Calixar 2
- Immutep S.A 2
- Integromics S.L. 2
- Ipsen 2
- LAB Research Inc. 2
- Neuroptis Biotech 2
- Prexton Therapeutics 2
- Promethera Biosciences S.A./N.V. 2
- sanofi-aventis Groupe 2
- 3d Communication 1
- Arteria SA 1
- Assistance Publique-Hôpitaux de Paris (AP-HP) 1
- Bertin Pharma Directions Parc d’activités du Pas du Lac 1
- BioBank for Life 1
- Biom'Up 1
- COVALAB S.A.R.L 1
- Cancer Immunotherapy Trials Network (CITN) 1
- Centre Léon Bérard 1
- CiToxLAB 1
- DNA Therapeutics SA 1
- Daiichi Sankyo Company, Limited 1
- EYETECHCARE, Limited 1
- Eli Lilly and Company 1
- Enterome 1
- European Patent Office (EPO) / Europäisches Patentamt (EPA) 1
- Exciva GmbH 1
- EyeBrain SA 1
- French National Institute of Health and Medical Research 1
- GlaxoSmithKline plc (GSK) 1
- Guerbet 1
- Harmonic Pharma 1
- Helios BioSciences 1
- ImmunID Technologies 1
- InGen BioSciences 1
- Inserm Transfert SA 1
- Institut Curie 1
- Inventiva 1
- Kallistem 1
- Katholieke Universiteit Leuven 1
- Lonza Group Ltd 1
- Max-Planck-Institut für Multidisziplinäre Naturwissenschaften 1
- Metabolium 1
- Michell Instruments GmbH 1
- MorphoSys AG 1
- Mutabilis SA 1
- NUTRITIS 1
- NexGenix Pharmaceuticals Holdings, Inc. 1
- NovAliX SAS 1
- OSEO 1
- Ono Pharmaceutical Co., Ltd. 1
- Oroxcell SAS 1
- Oxford Medical Diagnostics Ltd 1
- Pharma Omnium International SAS 1
- Pharma Plexus Holland BV 1
- PharmaDiagnostics NV 1
- Prestwick Chemical, Inc. 1
- PupPharma S.A.S. 1
- Quinten 1
- Regulaxis 1
- Ricerca Biosciences 1
- SOLVO Biotechnology 1
- Sebia 1
- Servier 1
- Spartha Medical 1
- Synthelis 1
- U. S. Food and Drug Administration (FDA) 1
- U.S. Patent & Trademark Office (USPTO) 1
- Université Pierre et Marie Curie 1
- Vésale Bioscience 1
- Xencor, Inc. 1
- instrAction GmbH 1